FDA Orange Book · active-ingredient family
Doxepin hydrochloride
Doxepin hydrochloride is approved as 5 brand and 78 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:SILENOR · NDA 022036
5
Brand (NDA)
78
Generics (ANDA)
16
Listed patents
0
Exclusivity periods
Brand (NDA) products · capsule, concentrate, cream, tablet
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| SILENORRLD×2 | CURRAX | NDA 022036 | AB | Mar 17, 2010 | |
| ZONALONRLD | MYLAN | NDA 020126 | AB | Apr 01, 1994 | |
| SINEQUANRLD×6 | PFIZER | NDA 016798 | — | Approved Prior to Jan 1, 1982 | |
| SINEQUANRLD | PFIZER | NDA 017516 | — | Approved Prior to Jan 1, 1982 | |
| DOXEPIN HYDROCHLORIDE×6 | NEW RIVER | NDA 016987 | — | Approved Prior to Jan 1, 1982 |
Generic (ANDA) products (78)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| DOXEPIN HYDROCHLORIDE | SUN PHARMA CANADA | ANDA 213919 | AB | Apr 28, 2026 | |
| DOXEPIN HYDROCHLORIDE×2 | TARO | ANDA 219058 | AB | Aug 06, 2025 | |
| DOXEPIN HYDROCHLORIDE×2 | AUROBINDO PHARMA LTD | ANDA 216041 | AB | Jul 25, 2024 | |
| DOXEPIN HYDROCHLORIDE×2 | AJANTA PHARMA LTD | ANDA 218564 | AB | Jul 01, 2024 | |
| DOXEPIN HYDROCHLORIDE×5 | UNIQUE | ANDA 217975 | AB | Aug 21, 2023 | |
| DOXEPIN HYDROCHLORIDE | AMNEAL | ANDA 212357 | AB | Aug 16, 2023 | |
| DOXEPIN HYDROCHLORIDE×2 | ZYDUS LIFESCIENCES | ANDA 202761 | AB | Aug 16, 2023 | |
| DOXEPIN HYDROCHLORIDE×5 | MICRO LABS | ANDA 217688 | AB | Jun 27, 2023 | |
| DOXEPIN HYDROCHLORIDE×2 | MSN | ANDA 214823 | BX | Apr 03, 2023 | |
| DOXEPIN HYDROCHLORIDE×5 | ZYDUS LIFESCIENCES | ANDA 210700 | BX | Mar 23, 2023 | |
| DOXEPIN HYDROCHLORIDE | ZYDUS LIFESCIENCES | ANDA 210140 | BX | Mar 21, 2023 | |
| DOXEPIN HYDROCHLORIDE | TEVA PHARMS | ANDA 215408 | AB | Feb 17, 2023 | |
| DOXEPIN HYDROCHLORIDE×5 | MSN | ANDA 215113 | AB | Jun 24, 2022 | |
| DOXEPIN HYDROCHLORIDE | ADAPTIS | ANDA 213796 | — | Apr 19, 2022 | |
| DOXEPIN HYDROCHLORIDE×5 | JUBILANT CADISTA | ANDA 215483 | AB | Mar 14, 2022 | |
| DOXEPIN HYDROCHLORIDE×5 | MANKIND PHARMA | ANDA 215710 | AB | Feb 09, 2022 | |
| DOXEPIN HYDROCHLORIDE×5 | ALEMBIC | ANDA 215076 | AB | Apr 21, 2021 | |
| DOXEPIN HYDROCHLORIDE×5 | APPCO | ANDA 214908 | AB | Apr 01, 2021 | |
| DOXEPIN HYDROCHLORIDE×5 | IXORA LIFESCIENCE | ANDA 211619 | AB | Mar 09, 2021 | |
| DOXEPIN HYDROCHLORIDE | VELZEN PHARMA PVT | ANDA 211618 | AB | Mar 01, 2021 | |
| DOXEPIN HYDROCHLORIDE×5 | EPIC PHARMA LLC | ANDA 210675 | AB | Oct 16, 2020 | |
| DOXEPIN HYDROCHLORIDE×5 | CHARTWELL RX | ANDA 210268 | AB | Sep 04, 2020 | |
| DOXEPIN HYDROCHLORIDE×5 | AIPING PHARM INC | ANDA 213474 | AB | Jul 28, 2020 | |
| DOXEPIN HYDROCHLORIDE×5 | LANNETT CO INC | ANDA 212997 | — | Jul 24, 2020 | |
| DOXEPIN HYDROCHLORIDE×2 | STRIDES PHARMA INTL | ANDA 202510 | AB | Jul 24, 2020 | |
| DOXEPIN HYDROCHLORIDE×5 | TARO | ANDA 213063 | — | Jul 01, 2020 | |
| DOXEPIN HYDROCHLORIDE×5 | AJANTA PHARMA LTD | ANDA 212624 | AB | Sep 13, 2019 | |
| DOXEPIN HYDROCHLORIDE×5 | AUROBINDO PHARMA LTD | ANDA 211603 | AB | Mar 27, 2019 | |
| DOXEPIN HYDROCHLORIDE×5 | AMNEAL PHARMS CO | ANDA 207482 | AB | Jun 28, 2017 | |
| DOXEPIN HYDROCHLORIDE×2 | RK PHARMA | ANDA 202337 | AB | Jan 20, 2016 | |
| DOXEPIN HYDROCHLORIDE×2 | ACTAVIS ELIZABETH | ANDA 201951 | AB | Jul 26, 2013 | |
| DOXEPIN HYDROCHLORIDE | PHARM ASSOC | ANDA 075924 | — | Jan 15, 2004 | |
| DOXEPIN HYDROCHLORIDE | LANNETT CO INC | ANDA 074721 | — | Dec 29, 1998 | |
| DOXEPIN HYDROCHLORIDE | WATSON LABS | ANDA 072985 | — | Mar 29, 1991 | |
| DOXEPIN HYDROCHLORIDE | WATSON LABS | ANDA 072986 | — | Mar 29, 1991 | |
| DOXEPIN HYDROCHLORIDE | WATSON LABS TEVA | ANDA 072987 | — | Mar 29, 1991 | |
| DOXEPIN HYDROCHLORIDE | PUREPAC PHARM | ANDA 073054 | — | Dec 28, 1990 | |
| DOXEPIN HYDROCHLORIDE | PUREPAC PHARM | ANDA 072109 | — | Dec 28, 1990 | |
| DOXEPIN HYDROCHLORIDE | PUREPAC PHARM | ANDA 073055 | — | Dec 28, 1990 | |
| DOXEPIN HYDROCHLORIDE | QUANTUM PHARMICS | ANDA 072375 | — | Mar 15, 1989 | |
| DOXEPIN HYDROCHLORIDE | QUANTUM PHARMICS | ANDA 072376 | — | Mar 15, 1989 | |
| DOXEPIN HYDROCHLORIDE | PUREPAC PHARM | ANDA 072386 | — | Sep 08, 1988 | |
| DOXEPIN HYDROCHLORIDE | PUREPAC PHARM | ANDA 072110 | — | Sep 08, 1988 | |
| DOXEPIN HYDROCHLORIDE | PUREPAC PHARM | ANDA 072387 | — | Sep 08, 1988 | |
| DOXEPIN HYDROCHLORIDE | PHARMOBEDIENT CNSLTG | ANDA 071918 | — | Jul 20, 1988 | |
| DOXEPIN HYDROCHLORIDE | SUN PHARM INDUSTRIES | ANDA 071502 | — | Feb 18, 1988 | |
| DOXEPIN HYDROCHLORIDE | SUN PHARM INDUSTRIES | ANDA 071653 | — | Feb 18, 1988 | |
| DOXEPIN HYDROCHLORIDE | SUN PHARM INDUSTRIES | ANDA 071654 | — | Feb 18, 1988 | |
| DOXEPIN HYDROCHLORIDE | SUN PHARM INDUSTRIES | ANDA 071521 | — | Feb 18, 1988 | |
| DOXEPIN HYDROCHLORIDE | WATSON LABS | ANDA 071763 | — | Feb 09, 1988 | |
| DOXEPIN HYDROCHLORIDE | WATSON LABS | ANDA 071764 | — | Feb 09, 1988 | |
| DOXEPIN HYDROCHLORIDE | DAVA PHARMS INC | ANDA 071685 | — | Jan 05, 1988 | |
| DOXEPIN HYDROCHLORIDE | DAVA PHARMS INC | ANDA 071686 | — | Jan 05, 1988 | |
| DOXEPIN HYDROCHLORIDE | DAVA PHARMS INC | ANDA 071673 | — | Jan 05, 1988 | |
| DOXEPIN HYDROCHLORIDE | DAVA PHARMS INC | ANDA 071674 | — | Jan 05, 1988 | |
| DOXEPIN HYDROCHLORIDE | DAVA PHARMS INC | ANDA 071675 | — | Jan 05, 1988 | |
| DOXEPIN HYDROCHLORIDE | DAVA PHARMS INC | ANDA 071676 | — | Jan 05, 1988 | |
| DOXEPIN HYDROCHLORIDE×6 | PH HEALTH | ANDA 071422 | — | Nov 09, 1987 | |
| DOXEPIN HYDROCHLORIDE | TEVA PHARMS | ANDA 071609 | — | Nov 09, 1987 | |
| DOXEPIN HYDROCHLORIDE | QUANTUM PHARMICS | ANDA 070972 | — | Sep 29, 1987 | |
| DOXEPIN HYDROCHLORIDE | QUANTUM PHARMICS | ANDA 070973 | — | Sep 29, 1987 | |
| DOXEPIN HYDROCHLORIDE | QUANTUM PHARMICS | ANDA 070931 | — | Sep 29, 1987 | |
| DOXEPIN HYDROCHLORIDE | QUANTUM PHARMICS | ANDA 070932 | — | Sep 29, 1987 | |
| DOXEPIN HYDROCHLORIDE | WATSON LABS | ANDA 071485 | — | Apr 30, 1987 | |
| DOXEPIN HYDROCHLORIDE | WATSON LABS | ANDA 071486 | — | Apr 30, 1987 | |
| DOXEPIN HYDROCHLORIDE | WATSON LABS | ANDA 071238 | — | Apr 30, 1987 | |
| DOXEPIN HYDROCHLORIDE | WATSON LABS | ANDA 071326 | — | Apr 30, 1987 | |
| DOXEPIN HYDROCHLORIDE | WATSON LABS | ANDA 071239 | — | Apr 30, 1987 | |
| DOXEPIN HYDROCHLORIDE | WATSON LABS | ANDA 070952 | — | Mar 04, 1987 | |
| DOXEPIN HYDROCHLORIDE | SANDOZ | ANDA 071487 | — | Mar 02, 1987 | |
| DOXEPIN HYDROCHLORIDE | SANDOZ | ANDA 071562 | — | Mar 02, 1987 | |
| DOXEPIN HYDROCHLORIDE | SANDOZ | ANDA 070827 | — | May 15, 1986 | |
| DOXEPIN HYDROCHLORIDE | SANDOZ | ANDA 070828 | — | May 15, 1986 | |
| DOXEPIN HYDROCHLORIDE | SANDOZ | ANDA 070825 | — | May 15, 1986 | |
| DOXEPIN HYDROCHLORIDE | WATSON LABS | ANDA 070953 | — | May 15, 1986 | |
| DOXEPIN HYDROCHLORIDE | WATSON LABS | ANDA 070954 | — | May 15, 1986 | |
| DOXEPIN HYDROCHLORIDE | WATSON LABS | ANDA 070955 | — | May 15, 1986 | |
| DOXEPIN HYDROCHLORIDE×5 | MYLAN PHARMS INC | ANDA 070791 | AB | May 13, 1986 |
Listed patents (16)
| Patent | Expires | In | Type |
|---|---|---|---|
| 9861607 | May 18, 2027 | in 11 mo | U-620 |
| 12083090 | May 18, 2027 | in 11 mo | U-620 |
| 9486437 | May 18, 2027 | in 11 mo | U-620 |
| 10238620 | May 18, 2027 | in 11 mo | U-620 |
| 10653662 | May 18, 2027 | in 11 mo | U-620 |
| 9572814 | Jul 20, 2027 | in 1 yr 1 mo | U-620 |
| 10653660 | Jul 20, 2027 | in 1 yr 1 mo | U-620 |
| 11110074 | Jul 20, 2027 | in 1 yr 1 mo | U-620 |
| 7915307 | Aug 24, 2027 | in 1 yr 2 mo | U-620 |
| 11234954 | Jan 18, 2028 | in 1 yr 7 mo | U-620 |
| 10548871 | Apr 11, 2028 | in 1 yr 10 mo | U-620 |
| 11096920 | Apr 11, 2028 | in 1 yr 10 mo | U-620 |
| 9907780 | Apr 11, 2028 | in 1 yr 10 mo | Product |
| 9107898 | May 01, 2028 | in 1 yr 11 mo | U-620 |
| 9532971 | Jun 01, 2029 | in 3 yr | Product |
| 8513299 | Sep 07, 2030 | in 4 yr 3 mo | U-620 |
Doxepin hydrochloride — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

